An FDA-registered compounding facility that follows current good manufacturing practice under section 503B.
Also known as: 503B pharmacy
Section 503B created a category of outsourcing facilities that register with the FDA and must follow current good manufacturing practice (CGMP) and undergo FDA inspection.
This oversight is more rigorous than for 503A compounding, though 503B products are still compounded rather than FDA-approved.